Literature DB >> 19368094

Incidence of type 1 diabetes mellitus and associated complications among children and young adults: results from Karnataka Diabetes Registry 1995-2008.

Prasanna Kumar1, Pushpa Krishna, Sanjay C Reddy, Mala Gurappa, S R Aravind, C Munichoodappa.   

Abstract

The purpose of this study was to estimate incidence of type 1 diabetes mellitus (T1DM) among children and young adults aged 0-25 years and to assess growth, glycaemic control, complications, risk factors and mortality associated diabetes mellitus,based on prospective registration of patients in Karnataka Diabetes Registry during the period 1995-2008. Complications were determined in subgroups serving as cohorts by screening tests and based on physicians' report. There were 1040 patients (514 boys and 526 girls) registered during the period 1995-2008. The overall incidence/prevalence of T1 DM (per 100,000 persons) was 3.8(0.32/10(5)/year) [males 3.7(0.3110(5)/year) and females 4(0.33/10(5)/year)]. On cross-sectional analysis of different cohorts, 88% (90/102) were below 50th percentile height, 95% (114/120) were <50th percentile of weight. Thirty-nine patients (10.7%) had poor glycaemic control (A1c>9%), The prevalence of different complications were as follows: Neuropathy 5.2% (12/230), retinopathy 8.4% (14/166), nephropathy 8.6% (20/230), hypertension 2.6% (6/230). Hypercholesterolaemia and hypertriglyceridaemia were found in 20.2% (24/119) and 41.7% (48/115) cases respectively and 18.1% (19/105) had low HDL. The percentage of patient with micro-albuminuria, high sensitive C-reactive protein were 29.6% (n=233) and 44.4% (20/45) respectively. Poor glycaemic control, hypertension and duration were strong consistent predictors of all complications. Twenty patients died during the period of which 10 deaths were related to diabetes. Though the incidence of diabetes in the young is low in our population compared to the western population, the burden of diabetes is high due to large population in our country. In spite of our best efforts there are still a huge gap between the standard of care and practice. Majority of type 1 diabetics are not reaching the ideal glycaemic targets.

Entities:  

Mesh:

Year:  2008        PMID: 19368094

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  23 in total

Review 1.  Cerebrovascular complications of diabetes: focus on stroke.

Authors:  Adviye Ergul; Aisha Kelly-Cobbs; Maha Abdalla; Susan C Fagan
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2012-06       Impact factor: 2.895

2.  Poststroke cognitive impairment and hippocampal neurovascular remodeling: the impact of diabetes and sex.

Authors:  Rebecca Ward; John Paul Valenzuela; Weiguo Li; Guangkuo Dong; Susan C Fagan; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-17       Impact factor: 4.733

Review 3.  Diabetes mellitus and its complications in India.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Nat Rev Endocrinol       Date:  2016-04-15       Impact factor: 43.330

4.  TLR2 knockout protects against diabetes-mediated changes in cerebral perfusion and cognitive deficits.

Authors:  Trevor Hardigan; Caterina Hernandez; Rebecca Ward; M Nasrul Hoda; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-02-22       Impact factor: 3.619

5.  Universal Nerve Conduction Screening in Type 1 Diabetes-Are We There Yet?

Authors:  Anurag Bajpai
Journal:  Indian J Pediatr       Date:  2022-01-14       Impact factor: 1.967

6.  Prevalence of type 1 diabetes mellitus in Karnal district, Haryana state, India.

Authors:  Sanjay Kalra; Bharti Kalra; Amit Sharma
Journal:  Diabetol Metab Syndr       Date:  2010-03-09       Impact factor: 3.320

7.  Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus.

Authors:  K Zorena; J Myśliwska; M Myśliwiec; K Rybarczyk-Kapturska; E Malinowska; P Wiśniewski; K Raczyńska
Journal:  J Hum Hypertens       Date:  2010-02-18       Impact factor: 3.012

8.  Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.

Authors:  Anders A F Sima; Weixian Zhang; Otto Muzik; Christian W Kreipke; José A Rafols; William H Hoffman
Journal:  Rev Diabet Stud       Date:  2009-11-10

9.  The beneficial effects of C-Peptide on diabetic polyneuropathy.

Authors:  Hideki Kamiya; Weixian Zhang; Anders A F Sima
Journal:  Rev Diabet Stud       Date:  2009-11-10

10.  NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.

Authors:  Rebecca Ward; Weiguo Li; Yasir Abdul; LaDonya Jackson; Guangkuo Dong; Sarah Jamil; Jessica Filosa; Susan C Fagan; Adviye Ergul
Journal:  Pharmacol Res       Date:  2019-02-25       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.